Safety and Efficacy Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis (P08648)

Clinical trial NCT00564421 · COMPLETED

Trial details

NCT number: NCT00564421
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Seasonal Allergic Rhinitis

Start date: 2007-12-18
Primary completion: 2008-02-14
Enrollment: 798

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.